TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/19 20:08 | 12/26/19 | DRNA | Dicerna Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Rosskamp Ralf | MA | O | Chief Me | M.d | 58 | 2.91 | 0 | 20 | 4 | D | ||||||||||||||||
12/27/19 20:08 | 12/26/19 | DRNA | Dicerna Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Rosskamp Ralf | MA | O | Chief Me | S.d | -454 | 22.69 | 0 | -20 | -85 | 4 | D | |||||||||||||||
11/8/06 19:24 | 11/6/06 | KOSP | Kos Pharmaceuticals Inc | FL | Health | Drug | Pharmaceutical Preparations | Rosskamp Ralf | O | EVP,Rese | M.d | 445 | 35.58 | 0 | 13 | 10 | D | ||||||||||||||||
11/8/06 19:24 | 11/6/06 | KOSP | Kos Pharmaceuticals Inc | FL | Health | Drug | Pharmaceutical Preparations | Rosskamp Ralf | O | EVP,Rese | S.d | -962 | 76.95 | 0 | -13 | -56 | 10 | D | |||||||||||||||
8/12/05 12:47 | 8/10/05 | KOSP | Kos Pharmaceuticals Inc | FL | Health | Drug | Pharmaceutical Preparations | Rosskamp Ralf | FL | O | EVP,Rese | M.d | 417 | 39.76 | 0 | 11 | 0 | D | |||||||||||||||
8/12/05 12:47 | 8/10/05 | KOSP | Kos Pharmaceuticals Inc | FL | Health | Drug | Pharmaceutical Preparations | Rosskamp Ralf | FL | O | EVP,Rese | S.d | -760 | 72.37 | 0 | -11 | -97 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |